Please assess the completion status of the following clinical trial:

Trial Title: Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients 18 years and older~2. Invasive mechanical ventilation ≥ 48 hours~3. Satisfy the US Centers for Disease Control and Prevention National Healthcare Safety Network VAP diagnostic criteria~   * At least one of the following:~     1. temperature \> 38 °C~    2. white blood cell count ≥ 12,000 cells/mm3 or ≤ 4,000 cells/mm3~    3. altered mental status with no other causes in \>70 year-olds; AND~  * Two or more chest imaging tests demonstrating at least one of the following:~     1. new and progressive OR progressive and persistent infiltrate~    2. new and persistent OR progressive and persistent consolidation~    3. new and persistent OR progressive and persistent cavitation, AND~  * At least two of the following:~     1. new onset of purulent sputum, or change in character of sputum, or increased respiratory secretions, or increased in suctioning requirements~    2. new onset or worsening tachypnea or dyspnea~    3. rales or bronchial breath sounds~    4. worsening gas exchange defined by oxygen desaturations (e.g., PaO2/FiO2 \<240), increased oxygen requirements or increased ventilation demand~Exclusion Criteria:~1. Poor likelihood of survival as defined by a Sepsis-related Organ Failure Assessment score (SOFA score) of \>11 points~2. Immunocompromised patients (HIV with CD4 \<200 cells/mm3, corticosteroids\> 0.5 mg/kg per day for \> 30 days, received chemotherapy in the past 3 months, solid organ or hematopoietic cell transplant)~3. Patients receiving antibiotic therapy for any other defined extra-pulmonary infections that warrant a duration of antibiotics longer than 7 days, or complications of pneumonia such as lung abscess or empyema, that warrant a duration of antibiotics longer than 7 days (excluding anti-tuberculosis treatment, antifungal medications, antibiotics meant for chronic suppression of chronic infections or chronic obstructive lung disease)~4. Patients who have been treated for VAP for more than 7 days from screening~5. Vulnerable population including prisoners and refugees

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Short antibiotic treatment duration for VAP (7 days or less) (Type: ACTIVE_COMPARATOR): None
- Long antibiotic treatment duration for VAP ( 8 days or more) (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).